Abbott recently awarded with the prestigious Golden Peacock Innovation Management Award at the 8th International Conference on Corporate Social Responsibility held in Bangalore.
The Golden Peacock Innovation Management Award honors organisations that have successfully embedded innovation into the basic tenets of their corporate cultures demonstrated in every function of the business and its operations. The Award aims to promote a ‘culture of innovation’ in India and recognises the efforts of companies that work toward strengthening this goal.
Abbott in India received the award in recognition of the company’s strong scientific heritage and leadership in innovation, commitment to an approach that caters to patients’ evolving needs, and its focus on institutionalised innovation.
“With over 12,000 employees in India, Abbott is committed to delivering healthcare solutions that are relevant to patients and consumers while providing value to physicians through our dedication to innovation in medicine, nutrition, devices, diagnostics and our overall business,” said Bhasker Iyer, Divisional Vice President, Established Pharmaceuticals, Abbott India. “Abbott’s success in driving its innovation agenda is deeply rooted in a philosophy that focuses on achieving results effectively and impactfully for the people of India.”
Over the years, Abbott has established a strong footprint in India, with a dedicated development centre for pharma in Mumbai and a state-of-the-art research and development centre for nutrition in Bangalore. These centres spearhead Abbott’s innovations for Indian requirements, many of which also have global application. Local innovation is important to Abbott and its employees, who are committed to advancing revolutionary technology and delivering localised innovation, which will translate into relevant products in the Indian market.
EP News Bureau – Mumbai
- Advertisement -
